Semax and Selank for anxiety and focus: what the evidence says

What did @jts.p3ts actually say?

After about a week on Semax and Selank, the creator reported noticeably improved attention and mood, no crash, and no side effects. They described Semax as stimulant-like and Selank as calming. Most significantly, they suggested these peptides are "a good alternative" for people trying to get off stimulants or benzos. That last claim is the one that needs serious scrutiny.

To be fair, they did disclaim that the peptides are "not a replacement to pharmaceuticals" in one breath, then effectively suggested they could substitute for controlled substances in the next. Those two statements contradict each other, and the contradiction matters a lot if someone is actually considering stopping a benzo prescription based on a TikTok.

Does the science back this up?

Partially, but the evidence base is thin and mostly Russian. Semax (ACTH 4-7 Pro-Gly-Pro) has real research behind it, but nearly all of it originates from Soviet-era and Russian state-funded studies, which carry significant replication and bias concerns for Western audiences.

On BDNF: the creator's claim that Semax "drives up BDNF" has some support. Dolotov et al. (2006, Journal of Neurochemistry) found intranasal Semax increased BDNF and its receptor TrkB in rat brain tissue. Whether that translates meaningfully to humans at doses people are actually using is unknown. There are no well-powered, placebo-controlled human trials on Semax for cognitive enhancement published in peer-reviewed Western journals.

For Selank, the anxiolytic mechanism involves modulation of GABA-A receptors and enkephalin metabolism. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reported reduced anxiety in animal models, and there is a small Russian clinical trial suggesting benefit in generalized anxiety disorder. But again, the sample sizes are small and the studies are not independently replicated.

What did they get wrong (or right)?

They got the general mechanism descriptions roughly right. Semax does appear to have nootropic and mild stimulant-adjacent properties in the literature. Selank does appear to have anxiolytic properties. Calling Semax "sort of like a stimulant, even though it's not" is actually a reasonable lay description.

The tolerance observation is also plausible. There is no published human data on Semax tolerance specifically, but the receptor dynamics involved, particularly around dopaminergic and serotonergic pathways, make experiential tolerance biologically credible.

What they got wrong, plainly: framing these as alternatives to benzos or stimulants for people trying to get off those drugs. Benzodiazepine discontinuation involves real physiological dependence, GABA receptor downregulation, and withdrawal that can include seizures. Recommending an unregulated research peptide as a substitute, even gently, without that context is irresponsible. Selank's GABA-adjacent mechanism does not make it a safe or validated substitute for benzo tapering. There is no clinical evidence supporting that use case.

What should you actually know?

Semax and Selank are not FDA-approved. In the United States, they exist in a regulatory gray zone, often sold by compounding pharmacies or research chemical suppliers. They are not Schedule I substances, but they are not approved drugs either. That means no standardized dosing, no quality controls guaranteed, and no clinical protocols established in the U.S.

If you are currently taking a benzo or a prescribed stimulant, the decision to reduce or stop that medication should involve your prescribing physician. Benzo discontinuation in particular carries real medical risk. A peptide with two small Russian trials behind it is not a validated exit strategy.

The creator's personal experience, feeling focused and calm with no side effects, is genuinely their experience. Anecdote is not nothing. But it also isn't evidence of safety or efficacy at a population level, and it certainly isn't a clinical recommendation. The "do your own research" sign-off does not transfer medical responsibility away from a creator who has made specific substitution suggestions to 27,000 viewers.